News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
869,102 Results
Type
Article (87880)
Company Profile (825)
Press Release (780382)
Multimedia
Podcasts (191)
Webinars (28)
Section
Business (233223)
Career Advice (4144)
Deals (39864)
Drug Delivery (145)
Drug Development (91395)
Employer Resources (203)
FDA (18377)
Job Trends (17417)
News (397830)
Policy (39958)
Tag
Academia (3006)
Academic (2)
Accelerated approval (31)
Adcomms (36)
Allergies (142)
Alliances (56981)
ALS (180)
Alzheimer's disease (1782)
Antibody-drug conjugate (ADC) (335)
Approvals (18543)
Artificial intelligence (611)
Autoimmune disease (154)
Automation (34)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (198)
Biotechnology (489)
Bladder cancer (158)
Brain cancer (64)
Breast cancer (644)
Cancer (4905)
Cardiovascular disease (433)
Career advice (3566)
Career pathing (40)
CAR-T (300)
CDC (59)
Celiac Disease (1)
Cell therapy (813)
Cervical cancer (37)
Clinical research (76875)
Collaboration (1743)
Company closure (5)
Compensation (1121)
Complete response letters (70)
COVID-19 (2987)
CRISPR (96)
C-suite (822)
Cystic fibrosis (154)
Data (6131)
Decentralized trials (2)
Denatured (70)
Depression (143)
Diabetes (524)
Diagnostics (7207)
Digital health (44)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (294)
Drug pricing (219)
Drug shortages (36)
Duchenne muscular dystrophy (232)
Earnings (100029)
Editorial (60)
Employer branding (25)
Employer resources (173)
Events (134943)
Executive appointments (1023)
FDA (21440)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1528)
Gene editing (210)
Generative AI (62)
Gene therapy (657)
GLP-1 (1108)
Government (5432)
Grass and pollen (8)
Guidances (382)
Healthcare (20941)
HIV (59)
Huntington's disease (48)
IgA nephropathy (86)
Immunology and inflammation (286)
Immuno-oncology (51)
Indications (83)
Infectious disease (3269)
Inflammatory bowel disease (201)
Inflation Reduction Act (17)
Influenza (118)
Intellectual property (237)
Interviews (816)
IPO (17952)
IRA (60)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (89)
Layoffs (656)
Leadership (39)
Legal (10156)
Liver cancer (97)
Longevity (14)
Lung cancer (669)
Lymphoma (368)
Machine learning (42)
Management (66)
Manufacturing (815)
MASH (171)
Medical device (14999)
Medtech (15043)
Mergers & acquisitions (22947)
Metabolic disorders (1363)
Multiple sclerosis (157)
NASH (23)
Neurodegenerative disease (339)
Neuropsychiatric disorders (92)
Neuroscience (3060)
NextGen: Class of 2026 (7707)
Non-profit (5107)
Now hiring (62)
Obesity (656)
Opinion (330)
Ovarian cancer (161)
Pain (198)
Pancreatic cancer (224)
Parkinson's disease (288)
Partnered (38)
Patents (488)
Patient recruitment (452)
Peanut (60)
People (66805)
Pharmaceutical (145)
Pharmacy benefit managers (31)
Phase I (23760)
Phase II (33355)
Phase III (25146)
Pipeline (4642)
Policy (328)
Postmarket research (3554)
Preclinical (10680)
Press Release (72)
Prostate cancer (237)
Psychedelics (53)
Radiopharmaceuticals (298)
Rare diseases (862)
Real estate (7437)
Recruiting (80)
Regulatory (28844)
Reports (65)
Research institute (2721)
Resumes & cover letters (651)
Rett syndrome (27)
RNA editing (19)
RSV (83)
Schizophrenia (157)
Series A (254)
Series B (193)
Service/supplier (30)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (175)
Sponsored (47)
Startups (4333)
State (2)
Stomach cancer (20)
Supply chain (111)
Tariffs (98)
The Weekly (119)
Vaccines (1127)
Venture capital (91)
Weight loss (453)
Women's health (84)
Worklife (21)
Date
Today (72)
Last 7 days (876)
Last 30 days (2236)
Last 365 days (33263)
2026 (1415)
2025 (33226)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (87)
Alaska (7)
Arizona (338)
Arkansas (14)
Asia (51479)
Australia (9033)
California (11300)
Canada (3252)
China (1128)
Colorado (476)
Connecticut (491)
Delaware (339)
Europe (118279)
Florida (1653)
Georgia (361)
Hawaii (3)
Idaho (68)
Illinois (938)
India (64)
Indiana (533)
Iowa (23)
Japan (412)
Kansas (132)
Kentucky (42)
Louisiana (29)
Maine (82)
Maryland (1437)
Massachusetts (8367)
Michigan (349)
Minnesota (647)
Mississippi (6)
Missouri (137)
Montana (35)
Nebraska (28)
Nevada (122)
New Hampshire (85)
New Jersey (3057)
New Mexico (33)
New York (2998)
North Carolina (1582)
North Dakota (10)
Northern California (5386)
Ohio (346)
Oklahoma (22)
Oregon (54)
Pennsylvania (2265)
Puerto Rico (20)
Rhode Island (49)
South America (1656)
South Carolina (62)
South Dakota (1)
Southern California (4350)
Tennessee (173)
Texas (1783)
United States (40900)
Utah (339)
Vermont (1)
Virginia (281)
Washington D.C. (85)
Washington State (949)
West Virginia (4)
Wisconsin (122)
Wyoming (2)
There are 869,102 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
JPM26: Novo Refocuses on Diabetes and Obesity Amid Push To Expand GLP-1 Market
After a period of diversification, Novo Nordisk is returning to its roots by focusing on the 2 billion people with diabetes, obesity or overweight.
January 14, 2026
·
3 min read
·
Nick Paul Taylor
Business
JPM26: Lilly Plots Path to Dominance as Obesity Market Enters a New Era
BMO analysts say Eli Lilly is well-positioned to maintain its lead in the ballooning weight loss space, predicting “strengthening leadership in obesity and beyond” as portfolios expand and patient access improves.
January 14, 2026
·
2 min read
·
Nick Paul Taylor
Business
JPM26 Day 2: Companies Lay Out Near-Term Revenue, Longer-Term Business Goals
Biopharma companies—including AstraZeneca, BioNTech and Agios—peered farther into the future on the second day of JPM, setting both revenue and R&D targets through the end of the decade.
January 14, 2026
·
4 min read
·
Tristan Manalac
Business
AstraZeneca’s Path to $80B by 2030 Paved With ADCs, Cell Therapies, Near-Term Product Launches
AstraZeneca is relying on several upcoming products to help hit its target of $80 billion in revenue by 2030, including drugs for hypertension, breast cancer and generalized myasthenia gravis, all of which are currently under FDA review.
January 14, 2026
·
2 min read
·
Tristan Manalac
GLP-1
FDA Asks Novo, Lilly To Remove Suicide Warnings From GLP-1 Weight Loss Products
A more detailed review of data by the FDA showed that GLP-1 drugs do not increase the risk of suicidal ideation or behavior.
January 14, 2026
·
1 min read
·
Tristan Manalac
Layoff Tracker
Lyra Shutters, EMD Serono Downsizes
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
January 14, 2026
·
44 min read
·
BioSpace Editorial Staff
Press Releases
Celltrion presents innovative drug pipeline and U.S. manufacturing and R&D expansion strategy at the 44th Annual J.P. Morgan Healthcare Conference
January 14, 2026
·
6 min read
Press Releases
Zomedica Announces “Fourth Friday at Four” Webinar on January 23rd Focused on Digital Innovation & Technology-Driven Growth
January 14, 2026
·
6 min read
Press Releases
Almirall Presents R&D Pipeline Advances Supported by Sustained Growth and Leadership in Medical Dermatology at J.P. Morgan Healthcare Conference
January 14, 2026
·
8 min read
Press Releases
New Study Identifies Signature in Blood to Better Predict Type 2 Diabetes Risk
January 14, 2026
·
6 min read
1 of 86,911
Next
